Data as of Jul 25, 2026 · Based on 2,718,867 AI responses across 9,511 prompts · See how Parse measures this
Talus Biotalus.bio · Low evidenceTalus Bio's platform measures and modulates the regulome—the body's control center for gene expression—in its native cellular context using AI-designed chemical libraries and functional proteomics. The company is developing a pipeline of first-in-class programs targeting transcription factors, cofactors, and splicing regulators for oncology, rare disease, and immune dysfunction.
Parse Score